Tag Archives: {Paclitaxel

oligopeptide synthesis in patients with recurrent ovarian cancer

There are currently at least 57 scientific studies underway to assess bevacizumab in the treatment method of gynecologic cancer, 45 of which focus on ovarian carcinoma. In addition, there are two not too long ago finished phase III trials evaluating … Continue reading

Posted in Antibody | Tagged , , , , | Leave a comment